- Category
- Micro (2024-25)
- Udyam number
- UDYAM-HR-13-0005762

About Medcliff Pharmaceuticals Private Limited
Data last updated:
Medcliff Pharmaceuticals Private Limited is a private limited company based in Panchkula, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 August 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24299HR2021PTC097228. Its GSTIN is 06AAOCM9015C1ZJ (Haryana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Himanshu Dogra and Mukesh Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No 23 Vill Railly Sector 12 – A Panchkula, Haryana, India – 134116.
As per the financials filed for FY 2025, the company reported a revenue of ₹93.68 Lakh, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹2.07 Lakh (net margin 2.2%) and EBITDA of ₹3.04 Lakh (EBITDA margin 3.3%). Revenue has grown at a compounded annual rate (CAGR) of 43% over three years.
As per MCA filings, the company has open charges of ₹20 Lakh on record.
Medcliff Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-13-0005762). For more details, the company can be reached via its website medcliffpharma.com.
Company details
Recognitions & Rankings of Medcliff Pharmaceuticals
Contact details
Medcliff Pharmaceuticals Private Limited's registered office is in Panchkula, Haryana. Its website is medcliffpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressH.No 23 Vill Railly Sector 12 – A Panchkula, Haryana, India – 134116
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Medcliff Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Medcliff Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Medcliff Pharmaceuticals Private Limited, buy the company report.
Financials of Medcliff Pharmaceuticals Private Limited
FY 2025 filings availableMedcliff Pharmaceuticals Private Limited reported revenue of ₹93.68 Lakh (up 2% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 43% over three years, including 2% growth in the latest year. EBITDA rose 17% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹3.04 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹2.07 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 3.3% | |||
| Net Profit Margin | 2.2% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Medcliff Pharmaceuticals Private Limited, buy the company report.
Board of directors of Medcliff Pharmaceuticals Private Limited
Medcliff Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Himanshu Dogra | Director | 26 Aug 2021 | 5 Years 2 Months | Current |
| Mukesh Sharma | Director | 26 Aug 2021 | 5 Years 2 Months | Current |
Peer comparison
Medcliff Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Teq Pharmaceuticals Private Limited | ₹94.02 Lakh (FY 2018) | 346.0% | Thane, Maharashtra, India | |||
| Medcliff Pharmaceuticals Private Limitedthis company | ₹93.68 Lakh (FY 2025) | ₹2.07 Lakh | 2.2% | 2.0% | Panchkula, Haryana, India | |
| Healogics Pharmaceuticals Private Limited | ₹93.51 Lakh (FY 2025) | -17.0% | Patna, Bihar, India | |||
| DVC Pharmaceuticals Private Limited | ₹93.48 Lakh (FY 2023) | 9347740.0% | Bhopal, Madhya Pradesh, India |
To see the full peer comparison of Medcliff Pharmaceuticals Private Limited, buy the company report.
Auditor
Medcliff Pharmaceuticals Private Limited is audited by G G S B & CO LLP for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| G G S B & CO LLP | FY 2022 | N500108 |
Shareholding
The shareholding of Medcliff Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Medcliff Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 06 Sep 2024 | 100975392 | Hdfc Bank Limited | ₹20 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Medcliff Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medcliff Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Medcliff Pharmaceuticals Private Limited has 1 active EPFO establishment as of Nov 12, 2026.
GST
Medcliff Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAOCM9015C1ZJ | Haryana | Active | 08 Nov 2021 |
To see the full GST registrations and return filing status of Medcliff Pharmaceuticals Private Limited, buy the company report.
Recent activity
Medcliff Pharmaceuticals Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Himanshu Dogra was appointed as Director on 26 Aug 2021.
Frequently asked questions
Medcliff Pharmaceuticals is an active private limited company based in Panchkula, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 26 August 2021 (5+ years old) and is registered under CIN U24299HR2021PTC097228.
Medcliff Pharmaceuticals has 2 current directors:
- Himanshu Dogra - Director
- Mukesh Sharma - Director
The latest financial statements of Medcliff Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Medcliff Pharmaceuticals is 06AAOCM9015C1ZJ, registered in Haryana.
The CIN (Corporate Identification Number) of Medcliff Pharmaceuticals is U24299HR2021PTC097228. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medcliff Pharmaceuticals was incorporated on 26 August 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Medcliff Pharmaceuticals by revenue are Teq Pharmaceuticals Private Limited, Healogics Pharmaceuticals Private Limited, DVC Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Himanshu Dogra was appointed as Director on 26 Aug 2021. Mukesh Sharma was appointed as Director on 26 Aug 2021.
Yes, Medcliff Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-13-0005762).
Medcliff Pharmaceuticals can be reached through the website medcliffpharma.com. Its registered office is in Panchkula, Haryana, India.
The registered office of Medcliff Pharmaceuticals is at H.No 23 Vill Railly Sector 12 – A Panchkula, Haryana, India – 134116.

